岐阜大学医学部 放射線科

menu

欧文論文業績 2022年

2022年

  1. Koyasu N, Hyodo F, Iwasaki R, Eto H, Elhelaly AE, Tomita H, Shoda S, Takasu M, Mori T, Murata M, Hara A, Noda Y, Kato H, Matsuo MSpatiotemporal imaging of redox status using in vivo dynamic nuclear polarization magnetic resonance imaging system for early monitoring of response to radiation treatment of tumor.
    Free Radic Biol Med. 2022; 179 : 170-180.
  2. Suto T, Kato H, Kawaguchi M, Matsuo M, Takiwaki M, Ogawa TReticular enhancement of the submandibular gland on contrast-enhanced magnetic resonance imaging in three cases with IgG4-related chronic sclerosing sialadenitis.
    Neuroradiol J. 2022; 35 (2) : 243-246.
  3. Kawaguchi M, Kato H, Matsuyama K, Noda Y, Hyodo F, Matsuo MPrognostic value of ¹⁸F-FDG PET/CT and MRI features in patients with high-risk and very-high-risk cutaneous squamous cell carcinoma.
    Br J Radiol. 2022; 95 (1132) : 20211003.
  4. Kawaguchi M, Kato H, Miyazaki T, Nagano A, Matsuo MImaging Findings of Calcaneal Cyst and Lipoma: Can Intraosseous Cyst Changes Into Lipoma With Advancing Age?
    J Comput Assist Tomogr. 2022; 46 (3) : 434-439.
  5. Kuroki M, Shibata H, Kuze B, Ohashi T, Kohyama K, Kato H, Kato H, Miyazaki T, Tomita H, Ogawa TGenetic Panel Test of Double Cancer of Signet-Ring Cell/Histiocytoid Carcinoma of the Eyelid and Papillary Thyroid Carcinoma: Case Report and Literature Review.
    Cureus. 2022; 14 (5) : e25192.
  6. Mori T, Kato H, Kawaguchi M, Hatano Y, Ishihara T, Noda Y, Hyodo F, Matsuo M, Furui T, Morishige KIA comparative analysis of MRI findings in endometrial cancer: differentiation between endometrioid adenocarcinoma, serous carcinoma, and clear cell carcinoma.
    Eur Radiol. 2022; 32 (6) : 4128-4136.
  7. Suto T, Kato H, Kawaguchi M, Kobayashi K, Miyazaki T, Ando T, Noda Y, Hyodo F, Matsuo M, Ishihara H, Ogawa TMRI findings of epithelial-myoepithelial carcinoma of the parotid gland with radiologic-pathologic correlation.
    Jpn J Radiol. 2022; 40 (6) : 578-585.
  8. Kaga T, Noda Y, Mori T, Kawai N, Miyoshi T, Hyodo F, Kato H, Matsuo MUnenhanced abdominal low-dose CT reconstructed with deep learning-based image reconstruction: image quality and anatomical structure depiction.
    Jpn J Radiol. 2022; 40 (7) : 703-711.
  9. Ota M, Hyodo F, Matsuo S, Kato T, Kawai N, Nakamura F, Fujimoto K, Kaneko Y, Kato H, Matsuo MInvestigation of the Clinical Efficacy of ⁹⁹ᵐTc-Sestamibi Washout in Patients with Acute Myocardial Infarction and Comparison with Stress Myocardial Imaging with ⁹⁹ᵐTc-Sestamibi Using a Two-Day Protocol.
    Iran J Radiol. 2022; 19 (2) : e122423.
  10. Kawaguchi M, Kato H, Kobayashi K, Miyazaki T, Nagano A, Noda Y, Hyodo F, Matsuo MMRI findings to differentiate musculoskeletal dedifferentiated liposarcoma from atypical lipomatous tumor.
    Radiol Med. 2022; 127 (12) : 1383-1389.
  11. Uno A, Yamamoto S, Iihara H, Fujii H, Makita C, Hayasaki Y, Ueda Y, Ito M, Takenaka M, Kumano T, Mori M, Yasue M, Kato-Hayashi H, Kobayashi R, Morishige KI, Matsuo M, Hayashi H, Suzuki AControl and Risk Factors of Nausea and Vomiting in Patients With Cervical Cancer Receiving Radiotherapy.
    Anticancer Res. 2022; 42 (6) : 3117-3123.
  12. Taniguchi T, Iinuma K, Nakano M, Kawase M, Takeuchi S, Kato D, Takai M, Nakane K, Ishihara T, Ito M, Kumano T, Matsuo M, Koie TChronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR® system.
    Prostate Int. 2022; 10 (4) : 207-212.
  13. Takeuchi S, Iinuma K, Nakano M, Kawase M, Kato D, Kawase K, Takai M, Nakane K, Ito M, Kumano T, Matsuo M, Koie TPatient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center.
    Prostate Int. 2022; 10 (4) : 224-228.
  14. Tomita N, Ishiyama H, Makita C, Ohshima Y, Nagai A, Baba F, Kuno M, Otsuka S, Kondo T, Sugie C, Kawai T, Takaoka T, Okazaki D, Torii A, Niwa M, Kita N, Takano S, Kawakami S, Matsuo M, Kumano T, Ito M, Adachi S, Abe S, Murao T, Hiwatashi ADaily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial.
    BMC Cancer. 2022; 22 (1) : 1259.
  15. Kawaguchi M, Kato H, Noda Y, Furui T, Morishige KI, Hyodo F, Matsuo MUterine extension determined by MRI: a useful parameter for differentiating subserosal leiomyomas from ovarian tumors.
    Abdom Radiol (NY). 2022; 47 (3) : 1142-1149.
  16. Kawai T, Matsuo M, Takakusagi Y, Saito K, Hyodo F, Devasahayam N, Matsumoto S, Kishimoto S, Yasui H, Yamamoto K, Krishna MCContinuous monitoring of postirradiation reoxygenation and cycling hypoxia using electron paramagnetic resonance imaging.
    NMR Biomed. 2022; 35 (10) : e4783.
  17. Mizuta Y, Akahoshi T, Eto H, Hyodo F, Murata M, Tokuda K, Eto M, Yamaura KNoninvasive Diagnosis of the Mitochondrial Function of Doxorubicin-Induced Cardiomyopathy Using In Vivo Dynamic Nuclear Polarization-Magnetic Resonance Imaging.
    Antioxidants (Basel). 2022; 11 (8) : 1454.
  18. Kawada H, Shoda S, Miyoshi T, Takasu M, Tanahashi Y, Iwasaki R, Nagata S, Kawai N, Noda Y, Goshima S, Hyodo F, Mori T, Matsuo MRadiological arterial anatomy in mature microminipigs as a pre-clinical research model in interventional radiology.
    Cardiovasc Intervent Radiol. 2022; 45 (5) : 705-708.
  19. Noda Y, Kawai N, Nagata S, Nakamura F, Mori T, Miyoshi T, Suzuki R, Kitahara F, Kato H, Hyodo F, Matsuo MDeep learning image reconstruction algorithm for pancreatic protocol dual-energy computed tomography: image quality and quantification of iodine concentration.
    Eur Radiol. 2022; 32 (1) : 384-394.
  20. Noda Y, Pisuchpen N, Mercaldo ND, Sekigami Y, Michelakos T, Parakh A, Wo JY, Qadan M, Ferrone C, Lillemoe KD, Ryan DP, Clark JW, Fernandez-Del Castillo C, Hong TS, Kambadakone ARArterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapy.
    Eur Radiol. 2022; 32 (4) : 2470-2480.
  21. Noda Y, Nakamura F, Kawamura T, Kawai N, Kaga T, Miyoshi T, Kato H, Hyodo F, Matsuo MDeep-learning image-reconstruction algorithm for dual-energy CT angiography with reduced iodine dose: preliminary results.
    Clin Radiol. 2022; 77 (2) : e138-e146.
  22. Noda Y, Tomita H, Ishihara T, Tsuboi Y, Kawai N, Kawaguchi M, Kaga T, Hyodo F, Hara A, Kambadakone AR, Matsuo MPrediction of overall survival in patients with pancreatic ductal adenocarcinoma: histogram analysis of ADC value and correlation with pathological intratumoral necrosis.
    BMC Med Imaging. 2022; 22 (1) : 23.
  23. Noda Y, Kawai N, Kawamura T, Kobori A, Miyase R, Iwashima K, Kaga T, Miyoshi T, Hyodo F, Kato H, Matsuo MRadiation and iodine dose reduced thoraco-abdomino-pelvic dual-energy CT at 40 keV reconstructed with deep learning image reconstruction.
    Br J Radiol. 2022; 95 (1134) : 20211163.
  24. Noda Y, Kawai N, Kaga T, Ishihara T, Hyodo F, Kato H, Kambadakone AR, Matsuo MVascular involvement and resectability of pancreatic ductal adenocarcinoma on contrast-enhanced MRI: comparison with pancreatic protocol CT.
    Abdom Radiol (NY). 2022; 47 (8) : 2835-2844.
  25. Ando T, Kato H, Matsuo MDifferent CT imaging findings between histological subtypes in patients with primary thyroid lymphoma.
    Radiol Med. 2022; 127 (2) : 191-198.
  26. Mizutani C, Matsuhashi N, Tomita H, Takahashi T, Suetsugu T, Tajima JY, Kiyama S, Yasufuku I, Tanaka Y, Okumura N, Murase K, Futamura M, Kawaguchi M, Ishihara T, Matsuo M, Miyazaki T, Hara A, Yoshida KPredictive Value of the Prognostic Nutritional Index in Neoadjuvant Chemoradiotherapy for Rectal Cancer.
    Cancer Diagn Progn. 2022; 2 (1) : 38-48.
  27. Ninomiya H, Ozeki M, Nozawa A, Yasue S, Endo S, Inuzuka M, Obara N, Mochizuki K, Kawaguchi M, Kaneko Y, Ohe N, Aoki Y, Matsuo M, Iwama T, Ohnishi HA rare pediatric case of McCune-Albright syndrome with acute visual disturbance: Case report.
    Medicine (Baltimore). 2022; 101 (6) : e28815.
  28. Tanaka O, Taniguchi T, Adachi K, Nakaya S, Kiryu T, Ukai A, Makita C, Matsuo MEffect of stomach size on organs at risk in pancreatic stereotactic body radiotherapy.
    Radiat Oncol. 2022; 17 (1) : 136.
  29. Nakano T, Aoyama H, Onodera S, Igaki H, Matsumoto Y, Kanemoto A, Shimamoto S, Matsuo M, Tanaka H, Oya N, Matsuyama T, Ohta A, Maruyama K, Tanaka T, Kitamura N, Akazawa K, Maebayashi K; Japanese Radiation Oncology Study Group 13-1 (JROSG13-1) InvestigatorsReduced-dose WBRT combined with SRS for 1-4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control.
    Clin Transl Radiat Oncol. 2022; 37 : 116-129.